GSA Capital Partners »

Outlook Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $190k 100k 1.89